MedPath

Protocol for the Evaluation of Dario™ BGMS Performance at Elevated Altitude

Not Applicable
Completed
Conditions
Diabetes
Interventions
Device: Dario Blood Glucose Monitoring System
Device: YSI Analyzer
Registration Number
NCT02352298
Lead Sponsor
LabStyle Innovations Ltd.
Brief Summary

The purpose of this study is to assess the performance of the Dario Blood Glucose Monitor (BGMS), at elevated altitudes, by obtaining whole blood fingerstick samples from individuals and analyzing the blood on the Dario Blood Glucose Monitor (BGMS) and comparing the readings to readings obtained from the YSI 2300 STAT Plus glucose analyzer.

Detailed Description

The study will be performed with 50 fresh capillary blood samples, collected by fingerstick using Dario single use lancet. Additional fingerstick with dedicated disposable lancets will be used to collect sufficient capillary fresh blood to be analyzed by the YSI 2300 STAT Plus analyzer. Additional fingersticks may be necessary if volume of blood from first fingerstick is insufficient.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Age of subject is 18 years or older
  • Able to speak and read English
Exclusion Criteria
  • Pregnant
  • Has any condition that the principal investigator believes may interfere in the subject's participation in the trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Dario Blood Glucose Monitoring SystemDario Blood Glucose Monitoring SystemBlood obtained via fingerstick and blood glucose level is tested on the Dario Blood Glucose Monitoring System
YSI STATYSI AnalyzerBlood obtained via fingerstick and blood glucose level is tested on the YSI STAT for comparison to the results obtained with the Dario Blood Glucose Monitoring System
Primary Outcome Measures
NameTimeMethod
Dario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003)6 seconds

Accuracy of Dario Blood Glucose Monitoring System when compared to Yellow Springs Instrument 2300 reference method at 10,152 feet above sea level. Acceptance criteria set per (International Organization for Standardization) ISO 15197:2003. Greater than or equal to 95% of the Dario results shall fall within plus or minus 15 mg/dL of the reference method value (for glucose concentrations \<75 mg/dL). For glucose concentrations greater than or equal to 75 mg/dL, the Dario results shall fall within plus or minus 20% of the reference method value.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Barbara Davis Center

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath